What Does J&J's Pause Mean for Investors?

Earlier this week, it was announced that injections of the
Johnson & Johnson (NYSE:JNJ) COVID-19 vaccine would be paused, due to six cases of a rare type of blood clot. The company's single-dose vaccine also had its rollout in the EU delayed, and was paused in South Africa as well.
Fortunately, as of April 14, almost a quarter of the U.S. population was fully vaccinated, and around 40% of the population had received at least one dose. As of the same date, according to a White House briefing, the J&J vaccine had accounted for fewer than 5% of the over 190 million recorded doses in the U.S.

Related Keywords

United States ,Israel ,Seychelles ,Maldives ,White House ,District Of Columbia ,South Africa ,San Marino ,Chile ,Bahrain ,Bhutan ,Americans ,Anthony Fauci ,Johnson ,Pfizer ,Centers For Disease Control Do ,Drug Administration ,Disease Control ,ஒன்றுபட்டது மாநிலங்களில் ,இஸ்ரேல் ,சீஷெல்ஸ் ,மாலத்தீவுகள் ,வெள்ளை வீடு ,மாவட்டம் ஆஃப் கொலம்பியா ,சான் மரினோ ,சிலி ,பஹ்ரைன் ,பூட்டான் ,அமெரிக்கர்கள் ,ஜான்சன் ,ஃபைசர் ,மையங்கள் க்கு நோய் கட்டுப்பாடு செய் ,நோய் கட்டுப்பாடு ,